TY - JOUR
T1 - The use of red flags during the referral chain of patients surgically treated for symptomatic spinal metastases
AU - van Tol, Floris R
AU - Kamm, Isabelle M L P
AU - Versteeg, Anne L
AU - Suijkerbuijk, Karijn P M
AU - Verkooijen, Helena M
AU - Oner, Cumher
AU - Verlaan, Jorrit-Jan
N1 - Funding Information:
This work was funded through an educational grant from DePuy Synthes (NLEA00196).
Publisher Copyright:
© Published by Oxford University Press on behalf of the Society for Neuro-Oncology and the European Association of Neuro-Oncology.
PY - 2023/6
Y1 - 2023/6
N2 - BACKGROUND: The use of so-called "red flags" may be beneficial in identifying patients with metastatic spinal disease. This study examined the utility and efficacy of these red flags in the referral chain of patients surgically treated for spinal metastases.METHODS: The referral chains from the onset of symptoms until surgical treatment for all patients receiving surgery for spinal metastases between March 2009 and December 2020 were reconstructed. The documentation of red flags, as defined by the Dutch National Guideline on Metastatic Spinal Disease, was assessed for each healthcare provider involved.RESULTS: A total of 389 patients were included in the study. On average, 33.3% of red flags were documented as present, 3.6% were documented as absent, and 63.1% were undocumented. A higher rate of red flags documented as present was associated with a longer time to diagnosis, but a shorter time to definitive treatment by a spine surgeon. Moreover, red flags were documented as present more often in patients who developed neurological symptoms at any point during the referral chain than those who remained neurologically intact.CONCLUSIONS: The association of red flags with developing neurological deficits highlights their significance in clinical assessment. However, the presence of red flags was not found to decrease delays prior to referral to a spine surgeon, indicating that their relevance is currently not sufficiently recognized by healthcare providers. Raising awareness of symptoms indicative of spinal metastases may expedite timely (surgical) treatment and thus improve treatment outcome.
AB - BACKGROUND: The use of so-called "red flags" may be beneficial in identifying patients with metastatic spinal disease. This study examined the utility and efficacy of these red flags in the referral chain of patients surgically treated for spinal metastases.METHODS: The referral chains from the onset of symptoms until surgical treatment for all patients receiving surgery for spinal metastases between March 2009 and December 2020 were reconstructed. The documentation of red flags, as defined by the Dutch National Guideline on Metastatic Spinal Disease, was assessed for each healthcare provider involved.RESULTS: A total of 389 patients were included in the study. On average, 33.3% of red flags were documented as present, 3.6% were documented as absent, and 63.1% were undocumented. A higher rate of red flags documented as present was associated with a longer time to diagnosis, but a shorter time to definitive treatment by a spine surgeon. Moreover, red flags were documented as present more often in patients who developed neurological symptoms at any point during the referral chain than those who remained neurologically intact.CONCLUSIONS: The association of red flags with developing neurological deficits highlights their significance in clinical assessment. However, the presence of red flags was not found to decrease delays prior to referral to a spine surgeon, indicating that their relevance is currently not sufficiently recognized by healthcare providers. Raising awareness of symptoms indicative of spinal metastases may expedite timely (surgical) treatment and thus improve treatment outcome.
KW - delay
KW - metastatic spinal disease
KW - red flags
KW - spinal metastases
KW - surgery
UR - http://www.scopus.com/inward/record.url?scp=85168792643&partnerID=8YFLogxK
U2 - 10.1093/nop/npad013
DO - 10.1093/nop/npad013
M3 - Article
C2 - 37188160
SN - 2054-2577
VL - 10
SP - 301
EP - 306
JO - Neuro-Oncology Practice
JF - Neuro-Oncology Practice
IS - 3
ER -